| Targeting potential drivers of COVID-19: Neutrophil extracellular traps BJ Barnes, JM Adrover, A Baxter-Stoltzfus, A Borczuk, J Cools-Lartigue, ... Journal of Experimental Medicine 217 (6), 2020 | 1671 | 2020 |
| Neutrophil extracellular traps in COVID-19 Y Zuo, S Yalavarthi, H Shi, K Gockman, M Zuo, JA Madison, C Blair, ... JCI Insight 5 (11), e138999, 2020 | 1643 | 2020 |
| NETs are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritis R Khandpur, C Carmona-Rivera, A Vivekanandan-Giri, A Gizinski, ... Science translational medicine 5 (178), 178ra40-178ra40, 2013 | 1436 | 2013 |
| Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19 Y Zuo, SK Estes, RA Ali, AA Gandhi, S Yalavarthi, H Shi, G Sule, ... Science translational medicine 12 (570), eabd3876, 2020 | 707 | 2020 |
| Peptidylarginine deiminase inhibition reduces vascular damage and modulates innate immune responses in murine models of atherosclerosis JS Knight, W Luo, AA O’Dell, S Yalavarthi, W Zhao, V Subramanian, ... Circulation research 114 (6), 947-956, 2014 | 443 | 2014 |
| Peptidylarginine deiminase inhibition disrupts NET formation and protects against kidney, skin and vascular disease in lupus-prone MRL/lpr mice JS Knight, V Subramanian, AA O'Dell, S Yalavarthi, W Zhao, CK Smith, ... Annals of the rheumatic diseases 74 (12), 2199-2206, 2015 | 433 | 2015 |
| To NET or not to NET: current opinions and state of the science regarding the formation of neutrophil extracellular traps S Boeltz, P Amini, HJ Anders, F Andrade, R Bilyy, S Chatfield, I Cichon, ... Cell Death & Differentiation 26 (3), 395-408, 2019 | 432 | 2019 |
| The 2023 ACR/EULAR antiphospholipid syndrome classification criteria M Barbhaiya, S Zuily, R Naden, A Hendry, F Manneville, MC Amigo, ... Arthritis & Rheumatology 75 (10), 1687-1702, 2023 | 409 | 2023 |
| Peptidylarginine deiminase inhibition is immunomodulatory and vasculoprotective in murine lupus JS Knight, W Zhao, W Luo, V Subramanian, AA O’Dell, S Yalavarthi, ... The Journal of clinical investigation 123 (7), 2981-2993, 2013 | 399 | 2013 |
| Release of neutrophil extracellular traps by neutrophils stimulated with antiphospholipid antibodies: a newly identified mechanism of thrombosis in the antiphospholipid syndrome S Yalavarthi, TJ Gould, AN Rao, LF Mazza, AE Morris, C Núñez‐Álvarez, ... Arthritis & rheumatology 67 (11), 2990-3003, 2015 | 380 | 2015 |
| Neutrophil extracellular traps and thrombosis in COVID-19 Y Zuo, M Zuo, S Yalavarthi, K Gockman, JA Madison, H Shi, W Woodard, ... Journal of thrombosis and thrombolysis 51 (2), 446-453, 2021 | 314 | 2021 |
| Patients with COVID-19: in the dark-NETs of neutrophils M Ackermann, HJ Anders, R Bilyy, GL Bowlin, C Daniel, R De Lorenzo, ... Cell Death & Differentiation 28 (11), 3125-3139, 2021 | 273 | 2021 |
| Plasma tissue plasminogen activator and plasminogen activator inhibitor-1 in hospitalized COVID-19 patients Y Zuo, M Warnock, A Harbaugh, S Yalavarthi, K Gockman, M Zuo, ... Scientific reports 11 (1), 1580, 2021 | 242 | 2021 |
| In vivo role of neutrophil extracellular traps in antiphospholipid antibody–mediated venous thrombosis H Meng, S Yalavarthi, Y Kanthi, LF Mazza, MA Elfline, CE Luke, DJ Pinsky, ... Arthritis & rheumatology 69 (3), 655-667, 2017 | 230 | 2017 |
| Neutrophil extracellular trap–derived enzymes oxidize high‐density lipoprotein: an additional proatherogenic mechanism in systemic lupus erythematosus CK Smith, A Vivekanandan‐Giri, C Tang, JS Knight, A Mathew, RL Padilla, ... Arthritis & rheumatology 66 (9), 2532-2544, 2014 | 229 | 2014 |
| EC5S Ubiquitin Complex Is Recruited by KSHV Latent Antigen LANA for Degradation of the VHL and p53 Tumor Suppressors QL Cai, JS Knight, SC Verma, P Zald, ES Robertson PLoS pathogens 2 (10), e116, 2006 | 222 | 2006 |
| Lupus neutrophils:‘NET’gain in understanding lupus pathogenesis JS Knight, MJ Kaplan Current opinion in rheumatology 24 (5), 441-450, 2012 | 221 | 2012 |
| The intersection of COVID-19 and autoimmunity JS Knight, R Caricchio, JL Casanova, AJ Combes, B Diamond, SE Fox, ... The Journal of clinical investigation 131 (24), 2021 | 211 | 2021 |
| Epstein–Barr virus latent antigen 3C can mediate the degradation of the retinoblastoma protein through an SCF cellular ubiquitin ligase JS Knight, N Sharma, ES Robertson Proceedings of the National Academy of Sciences 102 (51), 18562-18566, 2005 | 210 | 2005 |
| Proteins derived from neutrophil extracellular traps may serve as self-antigens and mediate organ damage in autoimmune diseases JS Knight, C Carmona-Rivera, MJ Kaplan Frontiers in immunology 3, 380, 2012 | 208 | 2012 |
Gautam SulePostdoctoral Fellow, Rheumatology, Department of Internal Medicine, University of MichiganVerified email at umich.edu
